American College of Cardiology2d
Prevalence of U.S. Overweight and Obesity, Consensus on CPR, Bleeding Risk Using NSAIDs With Anticoagulants
In this week’s View, Dr. Eagle looks at the prevalence of overweight and obesity among children, adolescents, and adults in the U.S., with forecasts up to 2050. He then discusses consensus ...
American College of Cardiology3d
Changes in Maximum Daily AF Duration, Stroke, and Mortality
Peigh G, Koehler J, Majumder S, et al. The investigators linked the Optum de-identified electronic health record (EHR) data set (2007-2021) with the Medtronic CareLink heart rhythm database. Patients ...
American College of Cardiology3d
CathPCI Registry: Safety and Feasibility of IVL as a Treatment For In-Stent Restenosis
Use of intravascular lithotripsy (IVL) for the treatment of in-stent restenosis (ISR), although off-label, may be safe and feasible, according to a study reviewing data from the ACC's CathPCI Registry ...
American College of Cardiology4d
FDA Update: Acoramidis Approved to Reduce CV Death, Hospitalization in Patients With ATTR-CM
The U.S. Food and Drug Administration (FDA) has approved acoramidis as a treatment to help reduce cardiovascular death and cardiovascular-related hospitalization in patients with transthyretin amyloid ...
American College of Cardiology4d
ACCEL Lite: Top Takeaways from 2024: CV Imaging with Thomas H. Marwick, MD, PhD, FACC
In this interview, Thomas H. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imaging. Dr. Marwick discusses the SCOT-HEART trial, ...
American College of Cardiology4d
Consensus on Platelet Function and Genetic Testing in PCI: Key Points
The following are key points to remember from a 2024 updated international consensus statement on platelet function and genetic testing in percutaneous coronary intervention (PCI): ...
American College of Cardiology4d
ACC.25 CV Team Section Call For Abstracts Now Open
Submissions for the CV Team and CV Pharmacists Poster Sessions at ACC.25, taking place March 29-31, 2025, in Chicago, IL, are now open. All members of the cardiovascular team are invited to submit ...
American College of Cardiology4d
Ablation as First-Line Treatment in Tolerated VT and LVEF >35%
Post-MI patients with an LVEF >35% who presented with hemodynamically tolerated VT, and who were noninducible for any VT after ablation, had an excellent long-term outcome. Overall, these data suggest ...
American College of Cardiology4d
Optimizing Cardiovascular Health in Pregnancy: Strategies For Preventing Maternal Mortality and Adverse Pregnancy Outcomes in the United States
Cardiovascular disease (CVD) is the leading cause of pregnancy-related maternal death in the United States, driven by rising rates of hypertension, diabetes mellitus (DM), obesity, smoking, and ...
American College of Cardiology5d
Prevalence of Overweight and Obesity in the US: Key Points
The following are key points to remember from a review on national- and state-level prevalence of overweight and obesity among children, adolescents, and adults in the United States (US), 1990–2021, ...
American College of Cardiology5d
Do CVD Events Precede a Diagnosis of T2D?
Individuals with type 2 diabetes (T2D) experienced two-fold more cardiovascular disease events than matched comparisons in the general population as much as 30 years before their diagnosis of T2D, ...
American College of Cardiology5d
Nonbacterial Thrombotic Endocarditis: Key Points
Nonbacterial thrombotic endocarditis (NBTE), previously known as marantic endocarditis, is a rare condition characterized by the formation of sterile vegetations on the surface of heart valves.